Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Pear Bio
company
About
Pear Bio is a computational biology company using organ-on-a-chip and computer vision to match cancer patients with effective treatments
- 11 - 50
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $14M
- Industries
- Biotechnology,Health Care,Medical
- Founded date
- Jan 1, 2017
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Pear Bio uses organ-on-a-chip and computer vision technology to recreate, visualize, and compute the human tumor microenvironment and its effects on cancer progression. The company was founded in 2017 and is headquartered in London.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$14M
Pear Bio has raised a total of
$14M
in funding over 2 rounds. Their latest funding was raised on
May 15, 2023 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 15, 2023 | Series A | $14M | 1 |
Octopus Ventures
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Pear Bio is funded by 1 investors.
Octopus Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Octopus Ventures
|
Yes | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
